Breast and Gynecologic Cancer
The Breast and Gynecologic Cancer Research Group conducts and fosters the development of research on the prevention and early detection of breast cancer, cervix and human papillomavirus (HPV)-related cancers, endometrial cancers, ovarian cancers, and precursor conditions related to these cancers.
Read more About the Breast and Gynecologic Cancer Research Group.
Staff
Funding Opportunities
Active Grants
Clinical Trials
Publications
Cancer Prevention Clinical Trials Network (CP-CTNet)
Research Centers develop and conduct early phase clinical trials to assess the preventive potential of agents and interventions of varying classes.
Phase 0/I/II Cancer Prevention Clinical Trials Program (Consortia)
Major medical research centers conduct systematic early clinical development of promising preventive agents.
US-Latin American-Caribbean Clinical Trials Network (ULACNet)
Partnership Centers will focus on improving prevention of human papillomavirus (HPV)-related cancers in human immunodeficiency virus (HIV)-infected individuals.
The ASCUS/LSIL Triage Study for Cervical Cancer (ALTS)
ALTS was a clinical trial to find the best way to help women and their doctors decide what to do about the mildly abnormal and very common Pap test results known as ASCUS and LSIL.
PREVENT and Consortia Project Results Presented at the AACR Annual Meeting 2019
NCI participated in the American Association for Cancer Research (AACR) Annual Meeting held March 29 - April 3, 2019 at Georgia World Congress Center in Atlanta, GA, including the presentation of research results from the latest PREVENT- and Consortia-supported projects.
Upcoming I-SCORE Workshop
The 2020 I-SCORE Workshop will be held April 16-17, 2020 at the NCI Shady Grove campus. Registration is required. View the announcement under DCP Meetings and Events.